VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Evolus, Inc. (EOLS) Total Return Calculator with Dividends Reinvested

Evolus, Inc.

Popular:

The total return for Evolus, Inc. (EOLS) stock is -45.56% over the past 12 months. So far it's down 5.95% this year. The 5-year total return is -27.10%, meaning $10,000 invested in EOLS stock 5 years ago would be worth $7,290 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in EOLS 1 year ago, it would be worth $5,374 today — you'd have lost $4,626.

With Dividends Reinvested$5,374-46.26%

Price Only (No DRIP)$5,374-46.26%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in EOLS

1Y$5,444-$4,556 (-45.6%)-45.6% CAGR

3Y$7,077-$2,923 (-29.2%)-10.9% CAGR

5Y$7,290-$2,710 (-27.1%)-6.1% CAGR

10Y$5,496-$4,504 (-45.0%)-5.8% CAGR

15Y$5,496-$4,504 (-45.0%)-3.9% CAGR

20Y$5,496-$4,504 (-45.0%)-2.9% CAGR

30Y$5,496-$4,504 (-45.0%)-2.0% CAGR

Evolus, Inc. did not pay dividends during this period. Total return = price return.

Loading EOLS total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-5.95%	—	-5.95%	—	$9,405
1Y	-45.56%	-45.56%	-45.56%	—	$5,444
3Y	-29.23%	-10.88%	-29.23%	—	$7,077
5Y	-27.10%	-6.13%	-27.10%	—	$7,290
10Y	-45.04%	-5.81%	-45.04%	—	$5,496
15Y	-45.04%	-3.91%	-45.04%	—	$5,496
20Y	-45.04%	-2.95%	-45.04%	—	$5,496
30Y	-45.04%	-1.98%	-45.04%	—	$5,496

Risk & Highlights

Best Year+103.44%2021

Worst Year-72.09%2020

Max Drawdown-67.38%2025-05-07 → 2026-03-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-36.01%	-36.01%	—	+0.41%	-36.4pp
2025	-40.14%	-40.14%	—	+16.64%	-56.8pp
2024	+10.51%	+10.51%	—	+24.00%	-13.5pp
2023	+34.48%	+34.48%	—	+24.81%	+9.7pp
2022	+6.98%	+6.98%	—	-19.95%	+26.9pp

EOLS underperformed the S&P 500 by 76.89pp over the past year (-45.56% vs +31.32%).

Loading summary...

EOLS Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
EOLSEvolus, Inc.	$416M	+51.9%	-6.0%	-45.6%	—	-29.2%	-27.1%	-45.0%
ABBVAbbVie Inc.	$362.6B	-0.8%	-9.1%	+13.1%	+3.6pp	+52.0%	+102.8%	+306.7%
ACLXArcellx, Inc.	$6.7B	+0.3%	+81.7%	+117.9%	—	+166.2%	+584.9%	+584.9%
SKINThe Beauty Health Company	$121M	+4.5%	-33.4%	-11.2%	—	-91.5%	-92.7%	-91.4%
INMDInMode Ltd.	$861M	-0.9%	-8.2%	-5.0%	—	-61.1%	-63.9%	+100.1%
AVAHAveanna Healthcare Holdings Inc.	$1.4B	+4.2%	-16.3%	+41.1%	—	+562.7%	-41.2%	-43.7%
MLABMesa Laboratories, Inc.	$585M	+12.4%	+33.6%	-9.6%	+0.5pp	-33.1%	-56.4%	+5.5%
IQVIQVIA Holdings Inc.	$29.9B	+3.4%	-21.7%	+20.7%	—	-7.0%	-23.7%	+167.5%
MCKMcKesson Corporation	$91.1B	-13.2%	-9.6%	+5.0%	+0.4pp	+104.0%	+308.4%	+351.9%
CAHCardinal Health, Inc.	$45.1B	-9.9%	-6.4%	+27.6%	+1.3pp	+134.8%	+256.4%	+174.5%
DOCSDoximity, Inc.	$5.2B	+11.4%	-40.7%	-55.0%	—	-25.2%	-51.5%	-51.5%

Compare:EOLS vs ABBV EOLS vs ACLX EOLS vs SKIN EOLS vs ABBV vs ACLX

About EOLS Dividend Returns

Evolus, Inc. (EOLS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of EOLS over the past year?

Evolus, Inc. (EOLS) delivered a return of -45.56% over the past year. Since EOLS does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in EOLS be worth today?

A $10,000 investment in Evolus, Inc. one year ago would be worth $5,444 today, representing a loss of $4,556.

Q3Does EOLS pay dividends?

Evolus, Inc. (EOLS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For EOLS, the total return equals the price-only return.

Q4Did EOLS beat the S&P 500?

No, Evolus, Inc. (EOLS) underperformed the S&P 500 by 76.89 percentage points over the past year. EOLS delivered a total return of -45.56%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed EOLS by 76.89pp during this period.

Q5What is EOLS's worst drawdown?

Evolus, Inc. (EOLS) experienced a maximum drawdown of -67.38% over the past year, declining from its peak on 2025-05-07 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is EOLS's long-term total return over 10, 20, or 30 years?

Here are Evolus, Inc. (EOLS)'s long-term returns with dividends reinvested. Over 10 years, the total return is -45.0% (-5.8% CAGR) — $10,000 would have grown to $5,496. Over 20 years: -45.0% total return (-2.9% CAGR) — $10,000 → $5,496. Over 30 years: -45.0% total return (-2.0% CAGR) — $10,000 → $5,496. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was EOLS's best and worst year?

Evolus, Inc.'s best calendar year was 2021 with a total return of 103.4%. Its worst year was 2020 with a total return of -72.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 175.5 percentage points.